CVE-2026-111226
Netgate pfSense CE 2.4.5 through 2.9.0 and Plus through 26.07 OS Command Injection via system_advanced_admin.php
- High 8.6
- A public exploit reference is listed
Description
pfSense CE 2.4.5 through 2.9.0 and Plus through 26.07 contains an OS command injection vulnerability that allows authenticated WebGUI users with Advanced Admin Access privilege to execute commands as root via Login Protection settings. Attackers can submit sshguard threshold, block time, or detection time values containing newlines or $(...) that are written unvalidated to sshguard.conf and sourced as root on restart.
Key facts
- Published
- 15 Oct 2026
- Last changed
- 18 Nov 2026
- Assigned by
- VulnCheck
- EPSS
- 7.216% likely to be exploited in the next 30 days, higher than 94.435% of CVEs (scores for 18 Nov 2026)
- SSVC (CISA)
- Exploitation: poc; Automatable: no; Technical impact: total
Severity scores
Each score is shown as its source gave it. They are not averaged or merged.
- 8.6CVSS 4.0, Highfrom the CNA (VulnCheck)
CVSS:4.0/AV:N/AC:L/AT:N/PR:H/UI:N/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N - 7.2CVSS 3.1, Highfrom the CNA (VulnCheck)
CVSS:3.1/AV:N/AC:L/PR:H/UI:N/S:U/C:H/I:H/A:H
Historical context and remediation
This reference retains the original CVE publication date. A recent record update does not mean a new attack occurred.
No separately sourced impact summary is available on this page yet. Consult the description, version data and dated exploitation evidence.
No explicit remediation statement is available on this page yet. Consult the original record and vendor references before choosing a fix.
Version statuses below come from the CNA. An “unaffected” version is not necessarily a currently supported release or proof of a patch date. EPSS is a dated risk estimate, not a count of historical attacks.
Affected products
| Vendor | Product | Versions |
|---|---|---|
| Netgate | pfSense CE |
|
| Netgate | pfSense Plus |
|
Timeline
- 15 Oct 2026 Published
Weakness
Practice this bug class
HackZoneLabs has a hands-on lab on OS command injection (CWE-78).